1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Supranuclear Palsy, Progressive: new trials by email Literature Review of Supranuclear Palsy, Progressive trials Research Report on Supranuclear Palsy, Progressive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) FNP-223, Placebo - Progressive Supranuclear Palsy | Phase 2 | Active not recruiting | Ferrer Internacional S.A. | 241 | 2024-07-23 | 2025-10-15 |
Basal Ganglia Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cranial Nerve Diseases (1) · Disease Attributes (1) · Eye Diseases (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Neurologic Manifestations (1) · Ocular Motility Disorders (1) · Ophthalmoplegia (1) · Paralysis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
France (1) · Germany (1) · Hungary (1) · Italy (1) · Poland (1) · Portugal (1) · Spain (1) · United Kingdom (1) · United States (1)